Literature DB >> 8107247

Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.

R Ramakrishnan1, D J Fink, G Jiang, P Desai, J C Glorioso, M Levine.   

Abstract

Competitive quantitative PCRs were used to examine the consequences of stereotactically injecting a highly attenuated herpes simplex virus type 1 mutant into rat brains. This mutant virus, designated RR1CAT/RR2lacZ, was engineered so that coding sequences of the genes UL39 and UL40 specifying the subunits of the viral ribonucleotide reductase were replaced by the chloramphenicol acetyltransferase (CAT) and the lacZ gene coding sequences, respectively. Stereotactic injection of this virus into the hippocampal region of the rat brain resulted in a localized infection. Viral gene products were visualized by immunochemical, cytochemical, or in situ hybridization techniques in the injected hippocampal region at 2 days postinjection. Viral genomes, represented by glycoprotein B (gB), latency-associated transcript (LAT), and lacZ sequences could be amplified by PCR from templates obtained by scraping hippocampal tissue off single 10-microns frozen sections. Both gB message and LAT could be detected by reverse transcriptase (RT)-PCR. At day 7 postinjection, neither CAT message, gB message, nor beta-galactosidase activity could be visualized by the same techniques, although viral DNA was detected by PCR and LAT could be detected by RT-PCR. A similar pattern was seen at 8 weeks, suggesting that latency was established by the mutant virus in cells of the injected hippocampus. By competitive quantitative PCR, hippocampal sections were determined to contain 2.6 x 10(5) genome equivalents (represented by the gB gene) on day 2, 6.2 x 10(4) on day 7, and 8.3 x 10(4) at 8 weeks. By competitive quantitative RT-PCR, the numbers of LAT molecules at the same time points were 3.2 x 10(6), 1.3 x 10(6), and 1.2 x 10(6), respectively. The numbers of LAT molecules per genome equivalent were 12.5, 20.3, and 14.5, respectively, being approximately the same for each of the three time points. The data permit the conclusion that the RR mutant virus establishes latency in the rat brain with the persistence of the viral genome and the production of LAT molecules. Once latency is established, the numbers of viral genomes and LAT RNA molecules remain constant. Thus the competitive quantitative PCR and RT-PCR techniques provide very sensitive and reliable methods to quantitate viral DNA and RNA present in infected tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107247      PMCID: PMC236649     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).

Authors:  T D Chung; J P Wymer; C C Smith; M Kulka; L Aurelian
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

2.  During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure.

Authors:  S L Deshmane; N W Fraser
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus.

Authors:  A T Dobson; F Sederati; G Devi-Rao; W M Flanagan; M J Farrell; J G Stevens; E K Wagner; L T Feldman
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  The herpesvirus protein kinase: a new departure in protein phosphorylation?

Authors:  D P Leader; F C Purves
Journal:  Trends Biochem Sci       Date:  1988-07       Impact factor: 13.807

5.  The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection.

Authors:  E K Wagner; W M Flanagan; G Devi-Rao; Y F Zhang; J M Hill; K P Anderson; J G Stevens
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames.

Authors:  S L Wechsler; A B Nesburn; R Watson; S M Slanina; H Ghiasi
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.

Authors:  D A Leib; C L Bogard; M Kosz-Vnenchak; K A Hicks; D M Coen; D M Knipe; P A Schaffer
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  Detection of herpes simplex virus type 1 gene expression in latently and productively infected mouse ganglia using the polymerase chain reaction.

Authors:  C Lynas; K A Laycock; S D Cook; T J Hill; W A Blyth; N J Maitland
Journal:  J Gen Virol       Date:  1989-09       Impact factor: 3.891

9.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

10.  Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.

Authors:  I Steiner; J G Spivack; R P Lirette; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  32 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.

Authors:  Hyung Hoan Lee; Soung Chul Cha; Dong June Jang; Jun Keun Lee; Dong Wan Choo; Young Sik Kim; Hong Sun Uh; Soo Young Kim
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

3.  Human herpesviruses in the cornea.

Authors:  S B Kaye; K Baker; R Bonshek; H Maseruka; E Grinfeld; A Tullo; D L Easty; C A Hart
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 4.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

5.  Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.

Authors:  Anna R Cliffe; David A Garber; David M Knipe
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

6.  The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 7.  Replication-defective herpes simplex virus vectors for gene transfer in vivo.

Authors:  P Marconi; D Krisky; T Oligino; P L Poliani; R Ramakrishnan; W F Goins; D J Fink; J C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 8.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

9.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

10.  Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors:  D J Surmeier; W J Song; Z Yan
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.